Authors

Rebecca Previs, MD
Recent : Emerging Front-Line Maintenance Therapies for Advanced Ovarian Cancer
ONCOLOGY Staff
Recent : Recap: Implications of TKI Plus Immunotherapy Combinations for RCC
Mitchell Steiner
Recent : 7 TiP Randomized, Multicenter, International Phase 3 ARTEST Study to Evaluate the Efficacy and Safety of Enobosarm Versus Active Control for the Treatment of AR+, ER+, HER2– Metastatic Breast Cancer in Patients Who Previously Received an Estrogen-Blocking Agent and CDK4/6 Inhibitor
Kerolos Rizk, MD
Recent : Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous Carcinosarcoma
Kristin M. Zimmerman Savill
Recent : 19 Real-world Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Talazoparib-Treated Patients With HER2-Negative, Locally Advanced or Metastatic Breast Cancer and Germline BRCA Mutations
Pat W. Whitworth
Recent : 37 The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device
Miguel A. Álvarez-Avitia, MD
Recent : Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma
Tu My To, PhD, MPH
Recent : Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab
Edmund Qiao
Recent : Key Presentations at ASCO 2021 Review Primary Prevention of Prostate Cancer in African American Men
Craig S. Sauter, MD
Recent : Current Treatment of Peripheral T-cell Lymphoma